1.Hemodynamics of Cerebral Arteriovenous Malformation.
Journal of Korean Neurosurgical Society 1990;19(10-12):1251-1257
The hemodynamic aspects of cerebral arteriovenous malformations(AVM) are currently the subject of increasing interest. Recently developed methods such as Doppler sonography, Xenon-enhanced Computed tomography Cerebral blood flow(CT CBF), single photon emission computed tomography(SPECT), and position emission tomography(PET) have promoted a more dynamic diagnostic and therapeutic approach to the complicated problem related to surgery of AVM. In this article, the literatures concerning the hemodynamics of cerebral AVM were reviewed.
Arteriovenous Malformations
;
Hemodynamics*
;
Intracranial Arteriovenous Malformations*
2.Two cases of Sheehan's syndrome.
Dal Soo KIM ; Bo Yeon KIM ; Jae Keun SUNWOO
Korean Journal of Obstetrics and Gynecology 1993;36(8):3366-3372
No abstract available.
Hypopituitarism*
3.X-linked agammaglobulinemia.
Dal Sik KIM ; Mi Yae YOON ; Hye Soo LEE
Korean Journal of Clinical Pathology 1991;11(3):545-548
No abstract available.
Agammaglobulinemia*
4.In vitro platelet assessment of the stored CPDA-1 platelet concentrates.
Kan Hee HAN ; Jang Soo SUN ; Nam Kyung KIM ; Jay Sik KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1992;3(2):143-150
No abstract available.
Blood Platelets*
5.Combined Treatment of Clioblastoma Multiforme with Operation, Radiation and Chemotherapy.
Ho Chung KIM ; Sang Chull LEE ; Dal Soo KIM
Journal of Korean Neurosurgical Society 1981;10(1):247-254
A patient with glioblastoma multiforme was treated with postoperative radiotherapy and a simultaneous induction chemotherapy with CCNU(75mg/sqm), procarbazine(100mg/sqm), vincristine(1.4mg/sqm). Follow up C-T scanning showed a mild decreased density area of left frontal lobe and the patient was discharged without any evidence of neurological deficit except mild decreased visual acuity.
Drug Therapy*
;
Follow-Up Studies
;
Frontal Lobe
;
Glioblastoma
;
Humans
;
Induction Chemotherapy
;
Radiotherapy
;
Visual Acuity
6.Diagnostic value of serum Troponin T measurements using EIA method in Acute Myocardial Infarction.
Yoon Jeong KIM ; Dal Sik KIM ; Hye Soo LEE ; Sam Im CHOI
Korean Journal of Clinical Pathology 1997;17(4):553-559
BACKGROUND: Cardiac troponin T (cTnT) is a new serological marker for use as a diagnostic toots for acute myocardial infarction (AMI). This study was designed to evaluate tee diagnostic efficiency of troponin T in AMI. METHODS: We determined the reference range of troponin T in 20 healthy adults without previous cardiovascular diseases and chest pain. We evaluated troponin-T, CK, LD, AST and CK-MB in serum of 13 AMI and 5 angina pectoris patients. The patients were arrived at the hospital within 3 hours after onset of (most recent) acute symptoms. Samples were drawn individually at the times of 0, 1, 3, 7, 18 and 24 hours after admission and continued at 6-h intervals for 2 days and 24-h intervals fort 2 weeks. Troponin T was determined by an enzyme-linked immuno-sorbent assay (one step sandwich assay) on an ES-300 analyzer. RESULTS: We found that serum troponin-T concentrations in healthy control adults were below 0.07microgram/L. The peak level of troponin-T concentration of patients with AMI was 22.0microgram/L, mean value, at 7 hours after admission and showed 110 times its discrimination limit value (0.2microgram/L). CK-MB value was normalized within 3 days after admission, but cTnT value remained high above its discrimination limit value until 2 weeks after admission during this study. CONCLUSIONS: The data indicate that the measurement of serum cTnT improves efficiency of serological testings of AMI as compared with conventionally used cardiac enzymes.
Adult
;
Angina Pectoris
;
Cardiovascular Diseases
;
Chest Pain
;
Discrimination (Psychology)
;
Humans
;
Myocardial Infarction*
;
Reference Values
;
Serologic Tests
;
Troponin T*
;
Troponin*
7.Gastrointestinal Adenomatous Polyposis Associated with Small Cell Neuroendocrine Carcinoma of the Rectosigmoid: A case report.
Wan Seop KIM ; Eun Kyung HONG ; Kang Sik KIM ; Kwang Soo LEE ; Jung Dal LEE
Korean Journal of Pathology 1996;30(11):1040-1044
In adenomatous polyposis coli there are many colonic and extracolonic manifestations, and various combinations of these induce different clinical presentations and syndromes. We experienced a unique case of adenomatous polyposis of the large intestine and stomach in a 39-year-old man. In the colon, small cell neuroendocrine carcinoma rather than adenocarcinoma had developed, which did not contain adenomatous or carcinomatous foci. The adenomatous polyps in the colon were all small and sessile with no cancerous or precancerous change two years after the resection of the symptomatic gastric adenomas, even though the gastric adenomas were larger and showed dysplastic change. We think this case is another variant of adenomatous polyposis syndrome.
Adenocarcinoma
;
Adenoma
8.Comparative Study of Anti-HCV by New HCV EIA, Immunoblotting and RT-PCR in Korean Blood Donors.
Sang Jin EUN ; Jang Soo SUH ; Won Kil LEE ; Jay Sik KIM ; In Soo KIM ; Jong Gyu KIM ; Dal Hyo SONG
Korean Journal of Blood Transfusion 1994;5(1):9-16
A newly developed third generation enzyme immunoassay(Lucky HCD 3.0 EIA) for hepatitis C virus(HCV) antibodies was added with the envelope(E1E2)/NS4 fusion proteins and expanded NS5 proteins as well as the core/NS3 fusion proteins. Authors evaluated the HCD 3.0 EIA with the previously available second generation EIA(HCD 2.0) in 10,435 Red Cross blood donors. Among 10,435 donors who were screened for the presence of HCV antibodies by HCD 2.0 assay, 22(0.21%) sera were repeatedly reactive. All of these sera were tested for further testing. Only 13 of all tested sera were reactive by HCD 3.0 EIA, and nine sera were not reactive. Nine of 13 HCD 3.0 positive sera were reactive by recombinant immunoblot assay(Lucky-Confirm). Also seven of these 13 sera had detectable HCV genomic RNA by reverse transcriptase-polymerase chain reaction(RT-PCR). None of nine HCD 3.0 negative samples had detectable immunoblot assay and HCV genomic RNA. It is concluded that the new HCV EIA can decrease a significant false positivity of second generation EIA in a blood donor population. This new assay correlates well with detection of HCV-RNA by RT-PCR and identifies donors who are truly infected.
Antibodies
;
Blood Donors*
;
Hepatitis C
;
Hepatitis C Antibodies
;
Humans
;
Immunoblotting*
;
Red Cross
;
RNA
;
Tissue Donors
9.Surgical Complication and Its Management in Ischemic Stroke.
Dal Soo KIM ; Do Sung YOO ; Pil Woo HUH ; Kyoung Suok CHO ; Joon Ki KANG
Journal of Korean Neurosurgical Society 2000;29(8):1107-1112
No abstract available.
Stroke*
10.Recent Clinical and Basic Research in Moyamoya Disease.
Journal of Korean Neurosurgical Society 1996;25(4):786-792
Moyamoya disease is an unusual form of chronic cerebrovascular occlusive disease characterized by bilateral stenosis and/or occlusion of distal internal carotid arteries and their vicinity, by a hazy network of collateral circulation at the base of brain called moyamoya vessels and clinically by recurrent ischemic attcks in children and by intracerebral hemorrhage in adult. This review included the trends of recent clinical and basic research in moyamoya disease, mainly selecting from recent annual reports published by the research committee on spontaneous occlusion of the circle of Willis(moyamoya disease) of the Ministry of Health and Welfare, Japan.
Adult
;
Brain
;
Carotid Artery, Internal
;
Cerebral Hemorrhage
;
Child
;
Collateral Circulation
;
Constriction, Pathologic
;
Epidemiology
;
Humans
;
Japan
;
Magnetic Resonance Angiography
;
Moyamoya Disease*
;
Positron-Emission Tomography